Articles in section Mergers & Acquisitions

<< Licensing

617 articles

Opinion & Analysis >>

Pages 1 2 3 4 5 .. 62

Next >>

Ipsen Acquires Epizyme to Broaden its Oncology Portfolio Published: 14 Jul-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 7
Vertex Buys ViaCyte for Diabetes Stem Cell Treatment Published: 14 Jul-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 7
AstraZeneca Acquires TeneoTwo in US$1.27 B Deal Published: 7 Jul-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 7
Galapagos Acquires CellPoint and AboundBio for Next-Generation Cell Therapies Published: 5 Jul-2022
By: Swati Sharan
Abstract Fulltext:
Volume: 2022 Issue: 7
Bristol Myers Squibb Buys Turning Point for US$4.1 B Published: 8 Jun-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 6
GlaxoSmithKline Acquires Affinivax for US$3.3 B Published: 3 Jun-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 6
Pfizer Buys Biohaven for US$11.6 B Published: 13 May-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 5
Caladrius and Cend Merge to Become Lisata Therapeutics Published: 30 Apr-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 4
Regeneron Bolsters I-O Portfolio with US$250 M Checkmate Acquisition Published: 21 Apr-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 4
GlaxoSmithKline Gets Momelotinib with US$1.9 B Sierra Oncology Buyout Published: 21 Apr-2022
By: Sasha Yachu
Abstract Fulltext:
Volume: 2022 Issue: 4

Login

Username:

Password:

Keep me logged in